文献速递心血管

瓣膜病及经导管瓣膜介入治疗中影像学应用价值试验

Trials Testing the Value of Imaging Use in Valve Disease and in Transcatheter Valvular Interventions.
PubMed 文献 · JACC Cardiovasc Imaging · 2017-01-01

本文指出影像学在瓣膜病诊断中的作用已获充分验证,但在指导治疗决策方面证据不足,随机试验数据显著缺乏。文章据此梳理了该领域最重要的知识空白,并定义了以成本效益方式推进瓣膜病患者诊疗的有意义机会。

要点

  • 影像学在瓣膜病诊断中的价值已获多年研究与验证确立。
  • 影像学在指导瓣膜病治疗决策方面的作用证据较少。
  • 该领域随机试验数据显著缺乏,存在重要知识空白。

核心结论

  • 影像学在瓣膜病诊断中作用明确,但在指导治疗决策方面随机试验数据显著缺乏,文章识别了知识空白并定义了推进诊疗的有意义机会。

研究设计与样本

  • 本文为综述性文章,未报告系统检索范围与纳入文献数量;文中提及PARTNER 3试验(NCT02675114)与美敦力低危患者经导管主动脉瓣置换试验(NCT02701283)。

局限性

  • 原文指出影像学在指导瓣膜病治疗决策方面的作用证据较少。
  • 原文指出该领域随机试验数据显著缺乏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The role of imaging in the diagnosis of valvular heart disease is well established through years of investigation and validation. However, the role of imaging in guiding the treatment decision-making for valvular heart disease is less well established, and there is a striking paucity of randomized trial data to help inform these decisions. Given this relative absence of randomized trial data, the present article highlights some of the most important knowledge gaps and defines meaningful opportunities for the field to help advance the care of patients with valvular heart disease in a cost-effective fashion. (The PARTNER 3-Trial: The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis [P3]; NCT02675114; Medtronic Transcatheter Aortic Valve Replacement in Low Risk Patients; NCT02701283).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Leipsic J, Bax JJ, Webb JG, et al. Trials Testing the Value of Imaging Use in Valve Disease and in Transcatheter Valvular Interventions. JACC Cardiovasc Imaging. 2017. PMID: 28279376. doi:10.1016/j.jcmg.2016.09.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。